Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA3 | P32297 | 6/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.41 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.41 |
| ▸ | CHRNG | P07510 | 1/20 | 0.41 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.41 |
| ▸ | CHRND | Q07001 | 1/20 | 0.41 |
| ▸ | CHRNA2 | Q15822 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7102097 | 1.00 | CHRNA3 (0.41) | CHRNA3CHRNB4CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL7098394 | 0.98 | CHRNA3 (0.42) | CHRNA3CHRNB4CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL7100478 | 0.84 | SCN10A (0.44) | CHRNA3CHRNB4CHRNB2CHRNA4SCN10A | |
| SCHEMBL7098064 | 0.84 | SCN10A (0.44) | CHRNA3CHRNB4CHRNB2CHRNA4SCN10A | |
| SCHEMBL7103327 | 0.82 | SCN10A (0.42) | CHRNA3CHRNB4CHRNB2CHRNA4SCN10A | |
| SCHEMBL7100975 | 0.75 | ROCK2 (0.36) | CHRNA3CHRNB4KDM1AGRM5 | |
| SCHEMBL7098027 | 0.75 | ROCK2 (0.36) | CHRNA3CHRNB4KDM1AGRM5 | |
| SCHEMBL7102129 | 0.73 | ROCK2 (0.34) | CHRNA3CHRNB4KDM1A | |
| SCHEMBL30375173 | 0.71 | CHRNB2 (0.46) | CHRNA3CHRNB4CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL29043100 | 0.71 | CHRNB2 (0.46) | CHRNA3CHRNB4CHRNB2CHRNA4CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003500402-A | — | — | 2003-01-07 | — | — | JP | claimed |
| CN-1361774-A | Heterocyclic substituted amino nitrogen heterocycles as central nervous system medicaments | ABBOTT INC (US) | 2002-07-31 | — | — | CN | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | claimed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | claimed |
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | disclosed |